Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.00 Up 0.22(3.24%) Jul 30, 4:00PM EDT
Prev Close:6.78
Open:6.88
Bid:6.67 x 2000
Ask:7.49 x 400
1y Target Est:12.14
Beta:2.94
Next Earnings Date: 5-Aug-14SNSS Earnings announcement
Day's Range:6.87 - 7.24
52wk Range:3.84 - 7.49
Volume:789,741
Avg Vol (3m):417,400
Market Cap:421.52M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNSS

Comparison

Symbol% ChgMkt Cap
SNSSUp 3.24%421.52M
AZNUp 0.11%92.29B
PFEDown 0.71%186.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.72
Quarterly EPS Est (Jun-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback